{"disease":{"id":"pulmonary-fibrosis-interstitial-lung-disease","name":"pulmonary fibrosis interstitial lung disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06528418","title":"Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"ChromX Health","has_results":false},{"nct_id":"NCT05382572","title":"Pulmonary Fibrosis Foundation Community Registry","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Pulmonary Fibrosis Foundation","has_results":false},{"nct_id":"NCT04016181","title":"The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":800,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT04708782","title":"Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":598,"lead_sponsor_name":"United Therapeutics","has_results":false},{"nct_id":"NCT05255991","title":"Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":597,"lead_sponsor_name":"United Therapeutics","has_results":false},{"nct_id":"NCT02713347","title":"Advancing Symptom Alleviation With Palliative Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":306,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT06883448","title":"Implementation of Home Monitoring in Patients With Pulmonary Fibrosis","phase":"NA","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT07396467","title":"Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT03261037","title":"A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period","phase":"NA","overall_status":"COMPLETED","enrollment_count":178,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT07269262","title":"SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers","phase":"NA","overall_status":"RECRUITING","enrollment_count":170,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT02036970","title":"Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":166,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT07486206","title":"Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":152,"lead_sponsor_name":"Hospital de Granollers","has_results":false},{"nct_id":"NCT05784207","title":"An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical Doctors","phase":"","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"Maastricht University","has_results":false},{"nct_id":"NCT03142191","title":"A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":138,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT04619680","title":"The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":121,"lead_sponsor_name":"Icahn School of Medicine at Mount Sinai","has_results":false},{"nct_id":"NCT07482917","title":"Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":92,"lead_sponsor_name":"Hospital de Granollers","has_results":false},{"nct_id":"NCT07201922","title":"A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Boehringer Ingelheim","has_results":false},{"nct_id":"NCT06636487","title":"Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Copenhagen University Hospital, Hvidovre","has_results":false},{"nct_id":"NCT06304207","title":"Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"MGH Institute of Health Professions","has_results":false},{"nct_id":"NCT05267418","title":"Effects of Automated Oxygen Titration Alone or With High Flow Nasal Therapy on Dyspnea and Exercise Tolerance","phase":"NA","overall_status":"TERMINATED","enrollment_count":30,"lead_sponsor_name":"Laval University","has_results":false},{"nct_id":"NCT01203943","title":"A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":28,"lead_sponsor_name":"Celgene","has_results":false},{"nct_id":"NCT04326036","title":"Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Black Tie Medical, Inc.","has_results":false},{"nct_id":"NCT04805086","title":"The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":5,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false}],"total":23},"guidelines":[],"source":"Drug Landscape verified database"}